Bloom Burton Investment Group Inc. Announces Acquisition of Preferred Shares of LED Medical Diagnostics Inc.

TORONTO, Sept. 4, 2018 /CNW/ - Bloom Burton Investment Group Inc. ("BBIG") reports that on September 4, 2018, it acquired 7,083,201 preferred shares (the "Preferred Shares") of LED Medical Diagnostics Inc. ("LED" or the "Company") through Bloom Burton Healthcare Lending Trust. The Preferred Shares were acquired in exchange for $3,187,440 of the Company's outstanding senior secured debentures, including accrued interest thereon, on a dollar-for-dollar basis at a price of $0.45 per Preferred Share (the "Debenture Exchange").

Prior to the Debenture Exchange, BBIG did not own or control any Preferred Shares. Immediately following the Debenture Exchange, BBIG owned a total of 7,083,201 Preferred Shares representing approximately 35% of the Company's issued and outstanding Preferred Shares.  

BBIG acquired the Preferred Shares for investment purposes. BBIG may from time to time acquire additional securities, dispose of some or all of the existing or additional securities or may continue to hold the securities of the Company.

The Company's head office is located at Suite 810, 580 Hornby Street, Vancouver, British Columbia, V6C 3B6.

To obtain a copy of the early warning report filed under applicable Canadian securities laws in connection with the transaction hereunder, please see the Company's profile on the SEDAR website www.sedar.com.

About Bloom Burton Investment Group Inc.

Bloom Burton Investment Group Inc. is a private asset manager existing under the laws of Ontario.

SOURCE Bloom Burton Investment Group Inc.

and to obtain a copy of the early warning report, please contact: Bloom Burton Investment Group Inc., 65 Front Street East, Suite 201, Toronto, ON M5E 1B5, Telephone: [phone], Attn: Michael Brown